These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9695982)

  • 21. Profiles of GBV-C/hepatitis G virus markers in patients coinfected with hepatitis C virus.
    Sauleda S; Reesink HJ; Esteban JI; Hess G; Esteban R; Guardia J
    J Med Virol; 1999 Sep; 59(1):45-51. PubMed ID: 10440807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HGV/GBV-C infection in liver transplant recipients: antibodies to the viral E2 envelope glycoprotein protect from de novo infection.
    Silini E; Belli L; Alberti AB; Asti M; Cerino A; Bissolati M; Rondinara G; De Carlis L; Forti D; Mondelli MU; Ideo G
    J Hepatol; 1998 Oct; 29(4):533-40. PubMed ID: 9824261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case-control study on GB virus C/hepatitis G virus infection and hepatocellular carcinoma. Brescia HCC Study.
    Tagger A; Donato F; Ribero ML; Chiesa R; Tomasoni V; Portera G; Gelatti U; Albertini A; Fasola M; Nardi G
    Hepatology; 1997 Dec; 26(6):1653-7. PubMed ID: 9398012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GB virus C/hepatitis G virus infection in HIV infected patients with haemophilia despite treatment with virus inactivated clotting factor concentrates.
    Woelfle J; Berg T; Bialek R; Keller KM; Effenberger W; Wagner N
    Arch Dis Child; 1999 May; 80(5):429-32. PubMed ID: 10208947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistence and clinical outcome of hepatitis G virus infection in pediatric bone marrow transplant recipients and children treated for hematological malignancy.
    Yamada-Osaki M; Sumazaki R; Tsuchida M; Koike K; Fukushima T; Matsui A
    Blood; 1999 Jan; 93(2):721-7. PubMed ID: 9885235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of GBV-C/hepatitis G virus RNA and E2 antibody among subjects infected with human immunodeficiency virus type 1 after parenteral or sexual exposure.
    Bourlet T; Guglielminotti C; Evrard M; Berthelot P; Grattard F; Frésard A; Lucht FR; Pozzetto B
    J Med Virol; 1999 Aug; 58(4):373-7. PubMed ID: 10421404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GBV-C/HGV in hemodialysis patients: anti-E2 antibodies and GBV-C/HGV-RNA in serum and peripheral blood mononuclear cells.
    Tribl B; Oesterreicher C; Pohanka E; Sunder-Plassmann G; Petermann D; Müller C
    Kidney Int; 1998 Jan; 53(1):212-6. PubMed ID: 9453021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and patterns of HGV/GBV-C infection in patients with suspected HCV-related hepatitis.
    García de Viedma D; Alonso R; Rivera M; Rodríguez-Créixems M; Bouza E
    Res Virol; 1998; 149(6):433-8. PubMed ID: 9923019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infection with hepatitis G virus among recipients of plasma products.
    Jarvis LM; Davidson F; Hanley JP; Yap PL; Ludlam CA; Simmonds P
    Lancet; 1996 Nov; 348(9038):1352-5. PubMed ID: 8918279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GB virus C/hepatitis G virus in serum and liver of patients with chronic C and non B non C hepatitis: molecular and immunological aspects.
    Essa EA; eI-Bendary A; el-Kalla FS; el-Shourbagy SH
    Egypt J Immunol; 2006; 13(2):1-10. PubMed ID: 18689266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of hepatitis G virus RNA and anti-E2 in a Japanese haemodialysis population.
    Shibuya A; Takeuchi A; Kamata K; Saigenji K; Kobayashi N; Yoshida A
    Nephrol Dial Transplant; 1998 Aug; 13(8):2033-6. PubMed ID: 9719160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of GB virus-C/hepatitis G virus infection in patients with cryptogenic chronic liver disease and in patients with primary biliary cirrhosis or Wilson's disease.
    Tagger A; Ribero ML; Larghi A; Donato F; Zuin M; Chiesa R; Benetti G; Ramella G; Borzio M; Podda M
    Am J Gastroenterol; 1999 Feb; 94(2):484-8. PubMed ID: 10022651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of GB virus C, HIV, and HCV infection markers in hemophiliacs exposed to non-inactivated or inactivated factor concentrates.
    Kupfer B; Ruf T; Matz B; Nattermann J; Spengler U; Rockstroh JK; Brackmann HH; Blümel J; Tacke M; Kaiser R
    J Clin Virol; 2005 Sep; 34(1):42-7. PubMed ID: 16087123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of hepatitis B, hepatitis C, and GB virus C/hepatitis G virus infections in liver disease patients and inhabitants in Ho Chi Minh, Vietnam.
    Kakumu S; Sato K; Morishita T; Trinh KA; Nguyen HB; Banh VD; Do HC; Nguyen HP; Nguyen VT; Le TT; Yamamoto N; Nakao H; Isomura S
    J Med Virol; 1998 Apr; 54(4):243-8. PubMed ID: 9557289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of GBV-C/hepatitis G virus viremia and anti-E2 in Canadian blood donors.
    Giulivi A; Slinger R; Tepper M; Sher G; Scalia V; Kessler G; Gill P
    Vox Sang; 2000; 79(4):201-5. PubMed ID: 11155070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GBV-C/HGV infection in end-stage renal disease: a serological and virological survey.
    Fabrizi F; Lunghi G; Pozzi C; Colzani S; Tentori F; Del Vecchio L; Corti M; Pagano A; Locatelli F
    J Nephrol; 2000; 13(1):68-74. PubMed ID: 10720218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infection with GB virus C/hepatitis G virus among blood donors and hemophiliacs in Martinique, a Caribbean island.
    Césaire R; Martial J; Maier H; Kerob-Bauchet B; Bera O; Duchaud E; Brebion A; Pierre-Louis S
    J Med Virol; 1999 Oct; 59(2):160-3. PubMed ID: 10459150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis G virus infection in patients with bleeding disorders.
    Wilde JT; Ahmed MM; Collingham KE; Skidmore SJ; Pillay D; Mutimer D
    Br J Haematol; 1997 Nov; 99(2):285-8. PubMed ID: 9375740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis G viral RNA in serum and in peripheral blood mononuclear cells and its relation to HCV-RNA in patients with clotting disorders.
    Sheng L; Soumillion A; Peerlinck K; Verslype C; Lin L; van Pelt J; Hess G; Vermylen J; Yap SH
    Thromb Haemost; 1997 May; 77(5):868-72. PubMed ID: 9184394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic infection with hepatitis G virus in relation to hepatocellular carcinoma among non-Asians in Los Angeles County, California.
    Yuan JM; Govindarajan S; Ross RK; Yu MC
    Cancer; 1999 Sep; 86(6):936-43. PubMed ID: 10491518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.